Chang Su

1.7k total citations
57 papers, 1.2k citations indexed

About

Chang Su is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Chang Su has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Hematology. Recurrent topics in Chang Su's work include Multiple Myeloma Research and Treatments (9 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related Molecular Pathways (3 papers). Chang Su is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related Molecular Pathways (3 papers). Chang Su collaborates with scholars based in China, United States and Hong Kong. Chang Su's co-authors include Yiou Cao, Kurt Hollfelder, Maurice K. Gately, Peter Ping Lin, A S Stern, J Hakimi, Ueli Gubler, Y C Pan, Jianwen Liu and Hua Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLANT PHYSIOLOGY.

In The Last Decade

Chang Su

52 papers receiving 1.2k citations

Peers

Countries citing papers authored by Chang Su

Since Specialization

Citations

This map shows the geographic impact of Chang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Su more than expected).

Fields of papers citing papers by Chang Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Su. The network helps show where Chang Su may publish in the future.

Co-authorship network of co-authors of Chang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Su. A scholar is included among the top collaborators of Chang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Su. Chang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A 2025 ·Journal of Crohn s and Colitis ·Jianyong Huang, Hao Ran, Xintong Zhang, Xue Li, Chang Su, Dong Lin, Chao Chen, Yayi He, Liu D, Xinjun Xu, (unknown), Ying Wang, (unknown), Jiwei Tian, Tian Liang, Jian Peng, Zhu Zhang	2
2	Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling pathway 2024 ·BMC Cancer ·(unknown), Fei Teng, Yuxin Lu, Yanqing Zhu, Xin Liang, Fanhong Wu, Jianwen Liu, Wenming Zhou, Chang Su, Yiou Cao	2
3	Case report: Bilateral facial palsy with paresthesias and positive anti-GT1a antibodies 2024 ·Frontiers in Immunology ·Xiaoxuan Xu, Zhihan Wang, Chang Su, Lin Cong, Dongming Zheng	0
4	Nano-energy interference: A novel strategy for blunting tumor adaptation and metastasis 2024 ·Materials Today Bio ·(unknown), Dong Fu, (unknown), (unknown), Mengxuan Yang, Chang Su, Ming Lei, Yiou Cao, Xiaodong Shen, Yi Chen, (unknown), (unknown)	1
5	The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review 2024 ·Infectious Agents and Cancer ·Chang Su, Lijun Huang, Liang Liang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hui Zhou, Ling Xiao	0
6	Natural variation in OsSEC13 HOMOLOG 1 modulates redox homeostasis to confer cold tolerance in rice 2023 ·PLANT PHYSIOLOGY ·Shuang Gu, Zhe Zhang, Jinquan Li, Jian Sun, Zhibo Cui, Fengcheng Li, Zhuang Jia, (unknown), Chang Su, Lian Wu, Xiao‐Liang Wang, Zhifu Guo, Hai Xu, Minghui Zhao, Dianrong Ma, (unknown)	11
7	Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus 2023 ·Biomedicines ·Chenchen Shi, Chang Su, (unknown), Lei Han, (unknown), (unknown), Xunlong Shi, Dianwen Ju, Yiou Cao, Haiyan Zhu	4
8	Mining Beneficial Genes for Salt Tolerance From a Core Collection of Rice Landraces at the Seedling Stage Through Genome-Wide Association Mapping 2022 ·Frontiers in Plant Science ·Xiaoliang Wang, Jinquan Li, (unknown), Shuang Gu, Jingbo Wang, Chang Su, Yueting Li, Dianrong Ma, Minghui Zhao, Wenfu Chen	5
9	The effect and mechanism of erianin on the reversal of oxaliplatin resistance in human colon cancer cells 2021 ·Cell Biology International ·Chang Su, Shaoqun Liu, Xiaoying Ma, Jiajun Liu, Jianwen Liu, Ming Lei, Yiou Cao	17
10	miR-488-5p promotes esophageal squamous cell carcinoma progression by suppressing the P53 pathway 2021 ·Journal of Thoracic Disease ·Chang Su, (unknown), Tao Jiang, Junfeng Liu	3
11	MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis 2017 ·BMC Cancer ·Shanyang He, Bing Liao, Yalan Deng, Chang Su, (unknown), (unknown), Shuzhong Yao, Lin Xu	39
12	Erianin inhibits indoleamine 2, 3-dioxygenase –induced tumor angiogenesis 2017 ·Biomedicine & Pharmacotherapy ·Chang Su, Peng Zhang, Jianwen Liu, Yiou Cao	59
13	Ciliate species diversity and its relationships with environmental factors in plateau swamp wetlands of southern Gansu Province, Northwest China in autumn 2013 ·Shengtaixue zazhi ·Chang Su	2
14	Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation 2011 ·Molecular Cancer Therapeutics ·Jiqin Lian, Zhenhong Ni, Xufang Dai, Chang Su, Amber R. Smith, Liang Xu, Fengtian He	42
15	Dual function of Zn2+ on the intrinsic excitability of dopaminergic neurons in rat substantia nigra 2010 ·Neuroscience ·Joseph J. Noh, Chang Su, (unknown), Jun-Mo Chung	13
16	MicroRNA‐23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin‐6 receptor 2010 ·FEBS Journal ·Li Zhu, Tao Liu, Hua Tang, (unknown), Chang Su, Min Liu, Xin Li	79
17	Elevated circulating endothelial microparticles and brachial–ankle pulse wave velocity in well-controlled hypertensive patients 2008 ·Journal of Human Hypertension ·Jie‐Mei Wang, Chang Su, Yanfang Wang, (unknown), Zhaohua Yang, Lei Chen, Fei Wu, (unknown), Jian Tao	63
18	The Relationship between Structure of Chitosan and Papain Activity 2002 ·Chang Su, Wenshui Xia, Yao Hui-yuan	2
19	Electroblotting proteolytic products from native gel for direct N‐terminal sequence analysis: An approach for studying protein‐protein interaction 1993 ·Electrophoresis ·(unknown), Chang Su, Kurt Hollfelder, (unknown), Yu‐Ching E. Pan	7
20	In vitro Chemosensitivity Assay of Human Urologie Malignancies 1989 ·European Urology ·M Y Yeh, Chang Su, Dawei Yu, Cong Ma, S H Han	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact